nodes	percent_of_prediction	percent_of_DWPC	metapath
Astemizole—CYP3A4—Temozolomide—malignant glioma	0.0979	1	CbGbCtD
Astemizole—CYP2J2—blood vessel—malignant glioma	0.0117	0.166	CbGeAlD
Astemizole—CYP2J2—telencephalon—malignant glioma	0.00568	0.0807	CbGeAlD
Astemizole—CYP2J2—medulla oblongata—malignant glioma	0.00446	0.0634	CbGeAlD
Astemizole—CYP2J2—midbrain—malignant glioma	0.00408	0.058	CbGeAlD
Astemizole—CYP2J2—spinal cord—malignant glioma	0.00398	0.0565	CbGeAlD
Astemizole—CYP2J2—central nervous system—malignant glioma	0.00323	0.0459	CbGeAlD
Astemizole—CYP2J2—cerebellum—malignant glioma	0.00316	0.0448	CbGeAlD
Astemizole—Flunarizine—CYP2B6—malignant glioma	0.00292	1	CrCbGaD
Astemizole—CYP2J2—brain—malignant glioma	0.00256	0.0364	CbGeAlD
Astemizole—KCNH2—telencephalon—malignant glioma	0.00242	0.0344	CbGeAlD
Astemizole—ABCB1—blood vessel—malignant glioma	0.00219	0.0311	CbGeAlD
Astemizole—HRH1—telencephalon—malignant glioma	0.00194	0.0276	CbGeAlD
Astemizole—KCNH2—medulla oblongata—malignant glioma	0.0019	0.027	CbGeAlD
Astemizole—KCNH2—midbrain—malignant glioma	0.00174	0.0247	CbGeAlD
Astemizole—KCNH2—spinal cord—malignant glioma	0.0017	0.0241	CbGeAlD
Astemizole—CYP2D6—brainstem—malignant glioma	0.00166	0.0236	CbGeAlD
Astemizole—CYP2D6—telencephalon—malignant glioma	0.00148	0.021	CbGeAlD
Astemizole—KCNH2—central nervous system—malignant glioma	0.00138	0.0196	CbGeAlD
Astemizole—KCNH2—cerebellum—malignant glioma	0.00134	0.0191	CbGeAlD
Astemizole—ABCB1—embryo—malignant glioma	0.00131	0.0186	CbGeAlD
Astemizole—ABCB1—retina—malignant glioma	0.00115	0.0164	CbGeAlD
Astemizole—HRH1—central nervous system—malignant glioma	0.0011	0.0157	CbGeAlD
Astemizole—KCNH2—brain—malignant glioma	0.00109	0.0155	CbGeAlD
Astemizole—ABCB1—telencephalon—malignant glioma	0.00106	0.0151	CbGeAlD
Astemizole—HRH1—brain—malignant glioma	0.000876	0.0124	CbGeAlD
Astemizole—CYP3A4—central nervous system—malignant glioma	0.000853	0.0121	CbGeAlD
Astemizole—CYP2D6—central nervous system—malignant glioma	0.000839	0.0119	CbGeAlD
Astemizole—ABCB1—medulla oblongata—malignant glioma	0.000834	0.0119	CbGeAlD
Astemizole—CYP2D6—cerebellum—malignant glioma	0.00082	0.0117	CbGeAlD
Astemizole—ABCB1—midbrain—malignant glioma	0.000763	0.0108	CbGeAlD
Astemizole—ABCB1—spinal cord—malignant glioma	0.000744	0.0106	CbGeAlD
Astemizole—CYP2D6—brain—malignant glioma	0.000666	0.00947	CbGeAlD
Astemizole—ABCB1—central nervous system—malignant glioma	0.000604	0.00858	CbGeAlD
Astemizole—ABCB1—cerebellum—malignant glioma	0.00059	0.00838	CbGeAlD
Astemizole—ABCB1—brain—malignant glioma	0.000479	0.00681	CbGeAlD
Astemizole—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000326	0.000394	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000325	0.000392	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000323	0.000389	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—BCAN—malignant glioma	0.000322	0.000389	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000318	0.000384	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—IDH1—malignant glioma	0.000309	0.000373	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—CAV1—malignant glioma	0.000309	0.000372	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MDK—malignant glioma	0.000306	0.000369	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—COX8A—malignant glioma	0.000304	0.000367	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—SPHK1—malignant glioma	0.000299	0.000361	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000295	0.000356	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—CXCR3—malignant glioma	0.000294	0.000354	CbGpPWpGaD
Astemizole—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000294	0.000354	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CYP2C18—malignant glioma	0.000293	0.000354	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—DTX1—malignant glioma	0.000292	0.000352	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—COX8A—malignant glioma	0.000287	0.000346	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—PIK3CG—malignant glioma	0.000281	0.000339	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—F2—malignant glioma	0.000279	0.000337	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000277	0.000334	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—PPARG—malignant glioma	0.000271	0.000327	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—BDKRB2—malignant glioma	0.000269	0.000324	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CXCR3—malignant glioma	0.000267	0.000322	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000263	0.000317	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—IDH2—malignant glioma	0.00026	0.000314	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000259	0.000312	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ASMT—malignant glioma	0.000259	0.000312	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000259	0.000312	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000259	0.000312	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000258	0.000311	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	0.000255	0.000308	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000255	0.000308	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.00025	0.000301	CbGpPWpGaD
Astemizole—HRH1—G alpha (q) signalling events—PIK3CA—malignant glioma	0.000248	0.000299	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—PIK3CD—malignant glioma	0.000247	0.000298	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—KNG1—malignant glioma	0.000244	0.000295	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CYP2B6—malignant glioma	0.000244	0.000295	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—BDKRB2—malignant glioma	0.000244	0.000294	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ASMT—malignant glioma	0.000244	0.000294	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—BCAN—malignant glioma	0.000243	0.000293	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.000241	0.000291	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000237	0.000287	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GSTT1—malignant glioma	0.000237	0.000286	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—SUFU—malignant glioma	0.000232	0.00028	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000232	0.00028	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—BCAN—malignant glioma	0.000229	0.000277	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HEY2—malignant glioma	0.000229	0.000276	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000226	0.000273	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—GFAP—malignant glioma	0.000224	0.00027	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—IDH1—malignant glioma	0.000223	0.00027	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PTGS1—malignant glioma	0.000222	0.000268	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—KNG1—malignant glioma	0.000222	0.000268	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	0.000222	0.000267	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000218	0.000263	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—SPHK1—malignant glioma	0.000216	0.000261	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—SPHK1—malignant glioma	0.000216	0.000261	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—PIK3CB—malignant glioma	0.000215	0.00026	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—PTGS2—malignant glioma	0.000213	0.000258	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CCR4—malignant glioma	0.000212	0.000256	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HEY1—malignant glioma	0.000212	0.000256	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CYP2C18—malignant glioma	0.000212	0.000256	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—BCHE—malignant glioma	0.000206	0.000249	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HIST1H3B—malignant glioma	0.000206	0.000248	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—SLC5A5—malignant glioma	0.000204	0.000246	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—CXCL8—malignant glioma	0.000197	0.000238	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—MMP3—malignant glioma	0.000197	0.000237	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000197	0.000237	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—IDH2—malignant glioma	0.000196	0.000237	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—JAG2—malignant glioma	0.000188	0.000227	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—COX8A—malignant glioma	0.000187	0.000226	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—PTEN—malignant glioma	0.000186	0.000225	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—IDH2—malignant glioma	0.000185	0.000223	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYP2B6—malignant glioma	0.000184	0.000222	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000181	0.000218	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000177	0.000213	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CYP2B6—malignant glioma	0.000174	0.00021	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GSTT1—malignant glioma	0.000171	0.000207	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—IDH1—malignant glioma	0.000169	0.000203	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000169	0.000203	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000167	0.000202	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GSTP1—malignant glioma	0.000164	0.000198	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—SPHK1—malignant glioma	0.000163	0.000197	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PTGS1—malignant glioma	0.000161	0.000194	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CAT—malignant glioma	0.00016	0.000193	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYP2C18—malignant glioma	0.00016	0.000193	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ASMT—malignant glioma	0.000159	0.000192	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—H3F3A—malignant glioma	0.000159	0.000192	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—IDH1—malignant glioma	0.000159	0.000192	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—F2—malignant glioma	0.000158	0.000191	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CXCR3—malignant glioma	0.000158	0.00019	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—SPHK1—malignant glioma	0.000154	0.000186	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000154	0.000185	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—YWHAE—malignant glioma	0.000153	0.000185	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NTRK2—malignant glioma	0.000153	0.000185	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—FLT1—malignant glioma	0.000153	0.000184	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—DUSP6—malignant glioma	0.000152	0.000183	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000151	0.000182	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—NCOR1—malignant glioma	0.000151	0.000182	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CYP2C18—malignant glioma	0.000151	0.000182	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—JAG1—malignant glioma	0.00015	0.000181	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—BCAN—malignant glioma	0.00015	0.000181	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NOTCH3—malignant glioma	0.000149	0.00018	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—BCHE—malignant glioma	0.000149	0.00018	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000149	0.000179	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—SLC5A5—malignant glioma	0.000147	0.000178	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—FBXW7—malignant glioma	0.000147	0.000177	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—BDKRB2—malignant glioma	0.000144	0.000174	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—F2—malignant glioma	0.000143	0.000173	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—AKT2—malignant glioma	0.000138	0.000167	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PIK3CG—malignant glioma	0.000137	0.000166	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PTPN11—malignant glioma	0.000135	0.000163	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NOTCH2—malignant glioma	0.000134	0.000162	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000133	0.00016	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—PIK3CA—malignant glioma	0.000131	0.000158	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—KNG1—malignant glioma	0.000131	0.000158	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GSTT1—malignant glioma	0.000129	0.000156	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—AKT2—malignant glioma	0.000126	0.000152	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000125	0.000151	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NTRK1—malignant glioma	0.000125	0.000151	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CAV1—malignant glioma	0.000123	0.000148	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GSTT1—malignant glioma	0.000122	0.000147	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PTGS1—malignant glioma	0.000121	0.000146	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—IDH2—malignant glioma	0.000121	0.000146	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PIK3CD—malignant glioma	0.000121	0.000146	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GSTP1—malignant glioma	0.000119	0.000143	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MMP3—malignant glioma	0.000116	0.00014	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000116	0.00014	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CAT—malignant glioma	0.000116	0.000139	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CDKN2B—malignant glioma	0.000115	0.000139	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PTGS1—malignant glioma	0.000114	0.000138	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CYP2B6—malignant glioma	0.000114	0.000137	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—BCHE—malignant glioma	0.000113	0.000136	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PIK3CG—malignant glioma	0.000112	0.000135	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PTK2—malignant glioma	0.000112	0.000135	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—CXCL8—malignant glioma	0.000111	0.000134	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—SLC5A5—malignant glioma	0.000111	0.000134	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HES1—malignant glioma	0.00011	0.000133	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NCOR1—malignant glioma	0.000109	0.000132	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—NCOR1—malignant glioma	0.000109	0.000132	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PPARG—malignant glioma	0.000108	0.000131	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—RAF1—malignant glioma	0.000108	0.00013	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—AKT1—malignant glioma	0.000107	0.000129	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—IL2—malignant glioma	0.000106	0.000128	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—BCHE—malignant glioma	0.000106	0.000128	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PIK3CB—malignant glioma	0.000105	0.000127	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—SLC5A5—malignant glioma	0.000105	0.000126	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PDGFRA—malignant glioma	0.000105	0.000126	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—IDH1—malignant glioma	0.000104	0.000125	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000102	0.000124	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—SPP1—malignant glioma	0.000102	0.000122	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CXCL8—malignant glioma	0.000101	0.000122	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—SPHK1—malignant glioma	0.000101	0.000121	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PIK3CD—malignant glioma	9.85e-05	0.000119	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CYP2C18—malignant glioma	9.85e-05	0.000119	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—IL2—malignant glioma	9.66e-05	0.000117	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TERT—malignant glioma	9.62e-05	0.000116	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PDGFB—malignant glioma	9.39e-05	0.000113	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—FGFR1—malignant glioma	9.34e-05	0.000113	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HIF1A—malignant glioma	9.2e-05	0.000111	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GSTP1—malignant glioma	8.96e-05	0.000108	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CAV1—malignant glioma	8.9e-05	0.000107	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CAV1—malignant glioma	8.89e-05	0.000107	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—KDR—malignant glioma	8.8e-05	0.000106	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CAT—malignant glioma	8.72e-05	0.000105	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PIK3CB—malignant glioma	8.59e-05	0.000104	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PTGS2—malignant glioma	8.51e-05	0.000103	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—F2—malignant glioma	8.47e-05	0.000102	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—FN1—malignant glioma	8.47e-05	0.000102	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GSTP1—malignant glioma	8.44e-05	0.000102	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—BAD—malignant glioma	8.37e-05	0.000101	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NOTCH1—malignant glioma	8.29e-05	0.0001	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—NCOR1—malignant glioma	8.23e-05	9.94e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CAT—malignant glioma	8.22e-05	9.91e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CD80—malignant glioma	8.12e-05	9.8e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—APC—malignant glioma	8.11e-05	9.78e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PIK3CG—malignant glioma	8.11e-05	9.78e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PIK3CG—malignant glioma	8.1e-05	9.78e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—EGF—malignant glioma	8.02e-05	9.67e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PTPN11—malignant glioma	7.97e-05	9.61e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GSTT1—malignant glioma	7.96e-05	9.61e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PPARG—malignant glioma	7.82e-05	9.44e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—NCOR1—malignant glioma	7.76e-05	9.36e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—BRAF—malignant glioma	7.62e-05	9.2e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PTGS1—malignant glioma	7.46e-05	9e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PTEN—malignant glioma	7.42e-05	8.95e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—AKT2—malignant glioma	7.42e-05	8.95e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—EGFR—malignant glioma	7.39e-05	8.91e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PIK3CD—malignant glioma	7.13e-05	8.6e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PIK3CD—malignant glioma	7.12e-05	8.59e-05	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—PIK3CA—malignant glioma	7.06e-05	8.52e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—KRAS—malignant glioma	6.98e-05	8.42e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—BCHE—malignant glioma	6.94e-05	8.37e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.85e-05	8.27e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—FGF2—malignant glioma	6.83e-05	8.24e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CAV1—malignant glioma	6.71e-05	8.1e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	6.41e-05	7.74e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MDM2—malignant glioma	6.39e-05	7.71e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—RAF1—malignant glioma	6.36e-05	7.68e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CAV1—malignant glioma	6.32e-05	7.63e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—ERBB2—malignant glioma	6.3e-05	7.6e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PIK3CB—malignant glioma	6.21e-05	7.5e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PIK3CB—malignant glioma	6.21e-05	7.49e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PTGS2—malignant glioma	6.15e-05	7.42e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PIK3CG—malignant glioma	6.11e-05	7.38e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CXCL8—malignant glioma	5.97e-05	7.2e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PPARG—malignant glioma	5.9e-05	7.12e-05	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—AKT1—malignant glioma	5.77e-05	6.96e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.76e-05	6.95e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CASP3—malignant glioma	5.71e-05	6.9e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IL2—malignant glioma	5.71e-05	6.89e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PPARG—malignant glioma	5.56e-05	6.71e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GSTP1—malignant glioma	5.52e-05	6.66e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MMP9—malignant glioma	5.4e-05	6.52e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PIK3CD—malignant glioma	5.37e-05	6.49e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CAT—malignant glioma	5.37e-05	6.48e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PTEN—malignant glioma	5.37e-05	6.48e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PTEN—malignant glioma	5.36e-05	6.47e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—AKT1—malignant glioma	5.24e-05	6.32e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PIK3CA—malignant glioma	5.24e-05	6.32e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—NCOR1—malignant glioma	5.07e-05	6.12e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PIK3CD—malignant glioma	5.06e-05	6.11e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—VEGFA—malignant glioma	4.85e-05	5.85e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—STAT3—malignant glioma	4.8e-05	5.79e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PIK3CB—malignant glioma	4.68e-05	5.65e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PTGS2—malignant glioma	4.64e-05	5.6e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MYC—malignant glioma	4.46e-05	5.38e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PIK3CB—malignant glioma	4.41e-05	5.33e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PTGS2—malignant glioma	4.37e-05	5.28e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—EGFR—malignant glioma	4.36e-05	5.27e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—AKT1—malignant glioma	4.28e-05	5.16e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CAV1—malignant glioma	4.14e-05	4.99e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—KRAS—malignant glioma	4.12e-05	4.97e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PTEN—malignant glioma	4.05e-05	4.88e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PTEN—malignant glioma	3.81e-05	4.6e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PIK3CA—malignant glioma	3.79e-05	4.57e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PIK3CA—malignant glioma	3.78e-05	4.57e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.77e-05	4.55e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TP53—malignant glioma	3.66e-05	4.42e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PPARG—malignant glioma	3.64e-05	4.39e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.31e-05	4e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—AKT1—malignant glioma	3.09e-05	3.73e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—AKT1—malignant glioma	3.09e-05	3.73e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.89e-05	3.48e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PTGS2—malignant glioma	2.86e-05	3.45e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PIK3CA—malignant glioma	2.86e-05	3.45e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.69e-05	3.25e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PTEN—malignant glioma	2.49e-05	3.01e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—AKT1—malignant glioma	2.33e-05	2.82e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—AKT1—malignant glioma	2.2e-05	2.65e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.76e-05	2.12e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—AKT1—malignant glioma	1.44e-05	1.73e-05	CbGpPWpGaD
